3.4. Ob-NAFLD Selectively Modulates Renal Antioxidant Enzymes, and Metformin Differentially Affects GST-P, SOD1, and SOD2 Levels. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.